Form 4: Vicarious Surgical CEO Adam Sachs Reports Sale of Shares to Cover Tax Obligations

Adam Sachs, CEO of Vicarious Surgical, sold 16,040 shares of Class A Common Stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Adam Sachs, the CEO, a director, and a 10% owner of Vicarious Surgical Inc., filed a Form 4 on March 5, 2024.
• On March 4, 2024, Sachs sold 16,040 shares of Class A Common Stock at a weighted average price of $0.3712 per share.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on June 2, 2023.
• Following the transaction, Sachs directly owns 1,735,050 shares of Class A Common Stock.
• A Power of Attorney was executed on January 30, 2024, granting authority to Adam Sachs, William Kelly, Erin Checka, Edwin C. Pease, Jason McCaffrey, Page Hubben, John Reilly, Robyn Frattali and Elizabeth Barber to execute forms related to securities transactions on behalf of the undersigned.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (sale of shares for tax obligations) by an insider, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that the CEO sold shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates